Related Experiment Video
Updated: Mar 17, 2026
Directed Cellular Self-Assembly to Fabricate Cell-Derived Tissue Rings for Biomechanical Analysis and Tissue Engineering
Published on: November 25, 2011
Tissue-Engineered Vascular Rings from Human iPSC-Derived Smooth Muscle Cells
Biraja C Dash1, Karen Levi2, Jonas Schwan3
1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Cardiovascular Research Center, Yale School of Medicine, New Haven, CT 06511, USA; Yale Stem Cell Center, Yale University, New Haven, CT 06510, USA; Department of Surgery (Plastic), Yale University, New Haven, CT 06520, USA.
Researchers developed a new method to create large quantities of human vascular smooth muscle cells (VSMCs) from stem cells. These cells can be used to engineer functional 3D vascular tissues for disease modeling and drug discovery.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Vascular Biology
Background:
- There is a critical need for scalable, renewable sources of functional human vascular smooth muscle cells (VSMCs).
- Patient-specific VSMC models are essential for studying vascular diseases and developing new therapies.
- Current methods for obtaining VSMCs are often limited in scale and efficiency.
Purpose of the Study:
- To derive a large quantity of functional human vascular smooth muscle cells (VSMCs) from human induced pluripotent stem cells (hiPSCs).
- To engineer robust 3D vascular tissue rings using these hiPSC-derived VSMCs for biomedical applications.
- To establish a platform for vascular tissue engineering, disease modeling, and drug screening.
Main Methods:
- Derivation of highly enriched, functional VSMCs from hiPSCs.
- Engineering of 3D vascular tissue rings via a one-step cellular self-assembly process.
- Characterization of the mechanical robustness and functionality of the engineered tissue rings.
Main Results:
- Successful derivation of large quantities of functional hiPSC-derived VSMCs.
- Fabrication of mechanically robust 3D vascular tissue rings.
- Demonstration of the utility of hiPSC-VSMC rings for modeling supravalvular aortic stenosis syndrome.
- Potential for broader application in studying other vascular proliferative diseases and drug screening.
Conclusions:
- A scalable and efficient platform technology for generating functional VSMCs from hiPSCs has been established.
- Engineered 3D vascular tissue rings offer a promising model for vascular disease research and regenerative medicine.
- This approach provides a valuable tool for advancing drug discovery and personalized therapies for vascular conditions.
